Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Children With Multiple Sclerosis”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Not applicableLooking for participantsNCT05258396
What this trial is testing

Exploring Cortical Remyelination in Children With Multiple Sclerosis

Who this might be right for
Children With Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris 40
Large-scale testing (Phase 3)UnknownNCT01730209
What this trial is testing

Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex

Who this might be right for
Tuberous Sclerosis ComplexTSC Related Cognitive DisabilityTSC Related Autism+1 more
Erasmus Medical Center 60
Not applicableActive Not RecruitingNCT06133049
What this trial is testing

Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their Infants

Who this might be right for
Multiple Sclerosis
Bristol-Myers Squibb 2,961
Testing effectiveness (Phase 2)Active Not RecruitingNCT04075266
What this trial is testing

Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hoffmann-La Roche 23
Not applicableStudy completedNCT01780441
What this trial is testing

Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)

Who this might be right for
Tuberous Sclerosis Complex
Boston Children's Hospital 166
Large-scale testing (Phase 3)Study completedNCT05323734
What this trial is testing

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

Who this might be right for
Tuberous Sclerosis Complex
Marinus Pharmaceuticals 129
Testing effectiveness (Phase 2)Looking for participantsNCT07161258
What this trial is testing

A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)

Who this might be right for
Relapsing Multiple Sclerosis
Hoffmann-La Roche 12
Not applicableLooking for participantsNCT03900221
What this trial is testing

French Registry for Monitoring Pregnancies for Multiple Sclerosis

Who this might be right for
Sclerosis, MultipleNeuromyelitis Optica Spectrum DisorderMyelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders+1 more
Hospices Civils de Lyon 1,500
Testing effectiveness (Phase 2)UnknownNCT03944447
What this trial is testing

Outcomes Mandate National Integration With Cannabis as Medicine

Who this might be right for
Chronic PainChronic Pain SyndromeChronic Pain Due to Injury+30 more
OMNI Medical Services, LLC 200,000
Large-scale testing (Phase 3)Ended earlyNCT05604170
What this trial is testing

Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy

Who this might be right for
Tuberous Sclerosis Complex
Marinus Pharmaceuticals 117
Not applicableUnknownNCT04832269
What this trial is testing

Effects of a Multiple Sclerosis Relapse Therapy on Offspring Neurocognitive Development and Behaviour

Who this might be right for
Multiple Sclerosis
Jena University Hospital 80
Not applicableUnknownNCT03326765
What this trial is testing

Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)

Who this might be right for
Sleep Disorder
Universitair Ziekenhuis Brussel 60
Not applicableEnrolling By InvitationNCT03836300
What this trial is testing

Parent and Infant Inter(X)Action Intervention (PIXI)

Who this might be right for
Fragile X SyndromeAngelman SyndromePrader-Willi Syndrome+11 more
RTI International 120
Early research (Phase 1)Study completedNCT01903681
What this trial is testing

Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances

Who this might be right for
Sleep Problems
Neurim Pharmaceuticals Ltd. 16
Large-scale testing (Phase 3)Study completedNCT01906866
What this trial is testing

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

Who this might be right for
Sleep Disorders
Neurim Pharmaceuticals Ltd. 125
Not applicableLooking for participantsNCT06764602
What this trial is testing

Observational, Retrospective, Multicenter, Nonprofit Study on the Prevalence of Renal Involvement in Pediatric Patients With Tuberous Sclerosis

Who this might be right for
Tuberous Sclerosis Complex (TSC)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 80
Not applicableUnknownNCT03979391
What this trial is testing

Isoelectric Focusing of Tears in Children With Radiologically Isolated or Clinically Isolated Syndrome

Who this might be right for
Clinically Isolated SyndromeRadiologically Isolated SyndromeMultiple Sclerosis in Children
Lille Catholic University 20
Not applicableLooking for participantsNCT04806620
What this trial is testing

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Who this might be right for
Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+41 more
Brain Inflammation Collaborative 10,000
Large-scale testing (Phase 3)Active Not RecruitingNCT05123703
What this trial is testing

Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Hoffmann-La Roche 188
Large-scale testing (Phase 3)Ended earlyNCT04485104
What this trial is testing

Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures

Who this might be right for
Seizure in Participants With Tuberous Sclerosis ComplexSeizure in Participants With Dravet SyndromeSeizure in Participants With Lennox-Gastaut Syndrome
Jazz Pharmaceuticals 3
Load More Results